BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

425 related articles for article (PubMed ID: 11779144)

  • 1. Fibrate and statin synergistically increase the transcriptional activities of PPARalpha/RXRalpha and decrease the transactivation of NFkappaB.
    Inoue I; Itoh F; Aoyagi S; Tazawa S; Kusama H; Akahane M; Mastunaga T; Hayashi K; Awata T; Komoda T; Katayama S
    Biochem Biophys Res Commun; 2002 Jan; 290(1):131-9. PubMed ID: 11779144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sterol regulatory element binding protein-mediated effect of fluvastatin on cytosolic 3-hydroxy-3-methylglutaryl-coenzyme A synthase transcription.
    Mascaró C; Ortiz JA; Ramos MM; Haro D; Hegardt FG
    Arch Biochem Biophys; 2000 Feb; 374(2):286-92. PubMed ID: 10666309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Statin-induced inhibition of the Rho-signaling pathway activates PPARalpha and induces HDL apoA-I.
    Martin G; Duez H; Blanquart C; Berezowski V; Poulain P; Fruchart JC; Najib-Fruchart J; Glineur C; Staels B
    J Clin Invest; 2001 Jun; 107(11):1423-32. PubMed ID: 11390424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Control of COX-2 gene expression through peroxisome proliferator-activated receptor gamma in human cervical cancer cells.
    Han S; Inoue H; Flowers LC; Sidell N
    Clin Cancer Res; 2003 Oct; 9(12):4627-35. PubMed ID: 14555539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of a pharmacological activation of PPAR on the expression of RAR and TR in rat liver.
    Bonilla S; Redonnet A; Noël-Suberville C; Groubet R; Pallet V; Higueret P
    J Physiol Biochem; 2001 Mar; 57(2):1-8. PubMed ID: 11579993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heat shock protein-90 (Hsp90) acts as a repressor of peroxisome proliferator-activated receptor-alpha (PPARalpha) and PPARbeta activity.
    Sumanasekera WK; Tien ES; Davis JW; Turpey R; Perdew GH; Vanden Heuvel JP
    Biochemistry; 2003 Sep; 42(36):10726-35. PubMed ID: 12962497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peroxisomal-proliferator-activated receptor alpha activates transcription of the rat hepatic malonyl-CoA decarboxylase gene: a key regulation of malonyl-CoA level.
    Lee GY; Kim NH; Zhao ZS; Cha BS; Kim YS
    Biochem J; 2004 Mar; 378(Pt 3):983-90. PubMed ID: 14641110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cross-talk between peroxisome proliferator-activated receptor (PPAR) alpha and liver X receptor (LXR) in nutritional regulation of fatty acid metabolism. II. LXRs suppress lipid degradation gene promoters through inhibition of PPAR signaling.
    Ide T; Shimano H; Yoshikawa T; Yahagi N; Amemiya-Kudo M; Matsuzaka T; Nakakuki M; Yatoh S; Iizuka Y; Tomita S; Ohashi K; Takahashi A; Sone H; Gotoda T; Osuga J; Ishibashi S; Yamada N
    Mol Endocrinol; 2003 Jul; 17(7):1255-67. PubMed ID: 12730332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered expression of nuclear hormone receptors and coactivators in mouse heart during the acute-phase response.
    Feingold K; Kim MS; Shigenaga J; Moser A; Grunfeld C
    Am J Physiol Endocrinol Metab; 2004 Feb; 286(2):E201-7. PubMed ID: 14701665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of peroxisome proliferator-activated receptor alpha on human angiotensinogen promoter.
    Shimamoto Y; Hirota K; Fukamizu A
    Int J Mol Med; 2004 May; 13(5):729-33. PubMed ID: 15067378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Down-regulation of STAT5b transcriptional activity by ligand-activated peroxisome proliferator-activated receptor (PPAR) alpha and PPARgamma.
    Shipley JM; Waxman DJ
    Mol Pharmacol; 2003 Aug; 64(2):355-64. PubMed ID: 12869640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcriptional regulation of cellular retinol-binding protein, type II gene expression in small intestine by dietary fat.
    Suruga K; Mochizuki K; Kitagawa M; Goda T; Horie N; Takeishi K; Takase S
    Arch Biochem Biophys; 1999 Feb; 362(1):159-66. PubMed ID: 9917340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different ways to regulate the PPARalpha stability.
    Blanquart C; Mansouri R; Fruchart JC; Staels B; Glineur C
    Biochem Biophys Res Commun; 2004 Jun; 319(2):663-70. PubMed ID: 15178457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nuclear receptors modulate the interaction of Sp1 and GC-rich DNA via ternary complex formation.
    Husmann M; Dragneva Y; Romahn E; Jehnichen P
    Biochem J; 2000 Dec; 352 Pt 3(Pt 3):763-72. PubMed ID: 11104684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The peroxisome proliferator-activated receptor delta, an integrator of transcriptional repression and nuclear receptor signaling.
    Shi Y; Hon M; Evans RM
    Proc Natl Acad Sci U S A; 2002 Mar; 99(5):2613-8. PubMed ID: 11867749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stabilization of peroxisome proliferator-activated receptor alpha by the ligand.
    Hirotani M; Tsukamoto T; Bourdeaux J; Sadano H; Osumi T
    Biochem Biophys Res Commun; 2001 Oct; 288(1):106-10. PubMed ID: 11594759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of endocytosis in the transactivation of nuclear factor-kappaB by oxidized low-density lipoprotein.
    Han CY; Park SY; Pak YK
    Biochem J; 2000 Sep; 350 Pt 3(Pt 3):829-37. PubMed ID: 10970799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cross-talk between peroxisome proliferator-activated receptor (PPAR) alpha and liver X receptor (LXR) in nutritional regulation of fatty acid metabolism. I. PPARs suppress sterol regulatory element binding protein-1c promoter through inhibition of LXR signaling.
    Yoshikawa T; Ide T; Shimano H; Yahagi N; Amemiya-Kudo M; Matsuzaka T; Yatoh S; Kitamine T; Okazaki H; Tamura Y; Sekiya M; Takahashi A; Hasty AH; Sato R; Sone H; Osuga J; Ishibashi S; Yamada N
    Mol Endocrinol; 2003 Jul; 17(7):1240-54. PubMed ID: 12730331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of the expression of peroxisome proliferator-activated receptor-dependent genes through disproportional expression of two subtypes in the small intestine.
    Mochizuki K; Suruga K; Kitagawa M; Takase S; Goda T
    Arch Biochem Biophys; 2001 May; 389(1):41-8. PubMed ID: 11370670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subtype- and response element-dependent differences in transactivation by peroxisome proliferator-activated receptors alpha and gamma.
    Kassam A; Hunter J; Rachubinski RA; Capone JP
    Mol Cell Endocrinol; 1998 Jun; 141(1-2):153-62. PubMed ID: 9723896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.